Literature DB >> 25164787

Visual dysfunction in patients with Parkinson's disease and essential tremor.

Ivanka Štenc Bradvica1, Mario Bradvica, Suzana Matić, Patricia Reisz-Majić.   

Abstract

The aim of this study was to determine the specificity and sensitivity of the Pelli-Robson and Ishihara diagnostic methods in differing Parkinson's disease from essential tremor compared to DaTSCAN (dopamine transporter scan) findings. The intention was to investigate whether visual dysfunction appears in the early state of Parkinson's disease. Therefore, we included patients with the symptomatology of parkinsonism lasting between 6 and 12 months. The study included 164 patients of which 59 (36.0%) suffered from Parkinson's disease, 51 (31.1%) from essential tremor, and 54 (32.9%) healthy patients which presented the control group. The specificity of Pelli-Robson test in confirming Parkinson's disease was 53% and the sensitivity 81.4%. The specificity of Ishihara test in confirming Parkinson's disease was 88.2%, and sensitivity 55.9%. We found that the colour and contrast dysfunction are present as the earliest symptoms of Parkinson's disease. In this study the Pelli-Robson test is highly sensitive and the Ishihara tables are highly specific in the differential diagnosis between Parkinson's disease and essential tremor, but neither of these methods fulfils the criteria for the validity of a test. We suggest performing both of these methods to evaluate which patients are indicated for DaTSCAN.

Entities:  

Mesh:

Year:  2014        PMID: 25164787     DOI: 10.1007/s10072-014-1930-2

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  34 in total

Review 1.  Essential tremor.

Authors:  Elan D Louis
Journal:  Lancet Neurol       Date:  2005-02       Impact factor: 44.182

2.  The letter contrast sensitivity test: clinical evaluation of a new design.

Authors:  Sharon A Haymes; Kenneth F Roberts; Alan F Cruess; Marcelo T Nicolela; Raymond P LeBlanc; Michael S Ramsey; Balwantray C Chauhan; Paul H Artes
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-06       Impact factor: 4.799

Review 3.  Non-motor parkinsonism.

Authors:  Ronald F Pfeiffer
Journal:  Parkinsonism Relat Disord       Date:  2007       Impact factor: 4.891

Review 4.  Functional and pharmacological organization of the retina: dopamine, interplexiform cells, and neuromodulation.

Authors:  J E Dowling
Journal:  Res Publ Assoc Res Nerv Ment Dis       Date:  1990

Review 5.  Exploring the relationship between essential tremor and Parkinson's disease.

Authors:  Joohi Shahed; Joseph Jankovic
Journal:  Parkinsonism Relat Disord       Date:  2006-08-02       Impact factor: 4.891

6.  Time course of nigrostriatal degeneration in parkinson's disease. A detailed study of influential factors in human brain amine analysis.

Authors:  P Riederer; S Wuketich
Journal:  J Neural Transm       Date:  1976       Impact factor: 3.575

7.  Color vision in Parkinson's disease and essential tremor.

Authors:  Y-S Oh; J-S Kim; S-W Chung; I-U Song; Y-D Kim; Y-I Kim; K-S Lee
Journal:  Eur J Neurol       Date:  2010-09-06       Impact factor: 6.089

Review 8.  Early diagnosis of Parkinson's disease.

Authors:  Alexandra Gaenslen; Daniela Berg
Journal:  Int Rev Neurobiol       Date:  2010       Impact factor: 3.230

9.  Visual thresholds to low-contrast pattern displacement, color contrast, and luminance contrast stimuli in Parkinson's disease.

Authors:  B A Haug; C Trenkwalder; G B Arden; W H Oertel; W Paulus
Journal:  Mov Disord       Date:  1994-09       Impact factor: 10.338

10.  Ophthalmologic features of Parkinson's disease.

Authors:  V Biousse; B C Skibell; R L Watts; D N Loupe; C Drews-Botsch; N J Newman
Journal:  Neurology       Date:  2004-01-27       Impact factor: 9.910

View more
  8 in total

1.  Advances in clinical neurology through the journal "Neurological Sciences" (2015-2016).

Authors:  Ilaria Di Donato; Antonio Federico
Journal:  Neurol Sci       Date:  2017-01       Impact factor: 3.307

Review 2.  Multimodal brain and retinal imaging of dopaminergic degeneration in Parkinson disease.

Authors:  Jee-Young Lee; Antonio Martin-Bastida; Ane Murueta-Goyena; Iñigo Gabilondo; Nicolás Cuenca; Paola Piccini; Beomseok Jeon
Journal:  Nat Rev Neurol       Date:  2022-02-17       Impact factor: 44.711

3.  Delayed saccade to perceptually demanding locations in Parkinson's disease: analysis from the perspective of the speed-accuracy trade-off.

Authors:  Makoto Kobayashi
Journal:  Neurol Sci       Date:  2016-07-25       Impact factor: 3.307

4.  Influence of obstacle color on locomotor and gaze behaviors during obstacle avoidance in people with Parkinson's disease.

Authors:  Tiago Penedo; Paula Fávaro Polastri; Sérgio Tosi Rodrigues; Lucas Simieli; André Macari Baptista; Gabriel Felipe Moretto; Luis Felipe Itikawa Imaizumi; Felipe Balistieri Santinelli; Fabio Augusto Barbieri
Journal:  Exp Brain Res       Date:  2018-09-25       Impact factor: 1.972

5.  Neuroanatomical substrates underlying contrast sensitivity.

Authors:  Ying Yang; Yajun Wang; Cun Zhang; Jiajia Zhu; Yongqiang Yu
Journal:  Quant Imaging Med Surg       Date:  2019-03

Review 6.  Retinal Degeneration: A Window to Understand the Origin and Progression of Parkinson's Disease?

Authors:  Yanyan Zhang; Xiaoguang Zhang; Yunhua Yue; Tian Tian
Journal:  Front Neurosci       Date:  2022-02-04       Impact factor: 4.677

7.  Contrast Acuity With Different Colors in Parkinson's Disease.

Authors:  Harsh V Gupta; Nan Zhang; Erika Driver-Dunckley; Shyamal H Mehta; Thomas G Beach; Charles H Adler
Journal:  Mov Disord Clin Pract       Date:  2019-09-06

Review 8.  Dopamine, Alpha-Synuclein, and Mitochondrial Dysfunctions in Parkinsonian Eyes.

Authors:  Alessia Indrieri; Rocco Pizzarelli; Brunella Franco; Elvira De Leonibus
Journal:  Front Neurosci       Date:  2020-10-19       Impact factor: 4.677

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.